wholly-owned subsidiary Sun Moral International (HK) Ltd. and by NeuroVive through its
subsidiary NeuroVivePharmaceutical Asia Ltd.
CicloMulsion° and NeuroSTAr are in clinical development by NeuroVive for the treatment ... partner to bring NeuroVive's drugs to market in China.
Mikael Bronnegard, CEO of NeuroVivePharmaceutical said: "Our agreement with Sihuan is a transformational event
for NeuroVive and provides strong ... China for traumatic brain injury will
be finalised during the course of 2013.
About NeuroVivePharmaceutical AB
NeuroVivePharmaceutical AB (http://www.neurovive.com/) the leading mitochondrial medicine company is
developing